Riskpilot← Back to searchSign inGet full accessINSULIN RESET ApS
APSActiveCVR 41511672Industrivej 38Business and other management consultancy activities · NACE 7020Est. 20201 employees
Revenue 2024
DKK -8K
-82% vs 2023
EBITDA margin
2684.6%
-973% vs 2023
Equity ratio
0.9%
Financial strength
Net profit 2024
DKK -205K
-197% vs 2023
| Revenue | DKK -8K | -82% |
| EBITDA | DKK -218K | -973% |
| Net profit | DKK -205K | -197% |
| Total assets | DKK 2,8M | +19% |
| Equity | DKK 26K | -89% |
| Employees | 1 | — |
Legal name
INSULIN RESET ApS
CVR number
41511672
Legal form
Anpartsselskab
NACE code
7020 · Business and other management consultancy activities
Founded
7. juli 2020
Share capital
DKK 47.059
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør og formanden for bestyrelsen i forening eller af den samlede bestyrelse.
Company purpose
Selskabets formål er drive virksomhed med rådgivning, forskning, produktion, køb og salg og formueforvaltning ud fra aktiviteter der udspringer af fokus på og fra insulin og dermed beslægtet virksomhed.
Address
Industrivej 38
Phone
+4561698831
Email
rocha@insulinreset.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | -115 | -122 | -46 | -8 |
| Staff expenses | -71 | -105 | -26 | -210 |
| EBITDA | -186 | -227 | -20 | -218 |
| Depreciation & amort. | -0 | -1 | -9 | -15 |
| EBIT | -186 | -228 | -29 | -233 |
| Net financials | -2 | -24 | -72 | -34 |
| Profit before tax | -188 | -253 | -101 | -267 |
| Tax | -72 | -125 | -32 | -63 |
| Net profit | -115 | -127 | -69 | -205 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 909 | 1.872 | 2.400 | 2.846 |
| Equity | 425 | 300 | 231 | 26 |
| Long-term debt | 0 | 0 | 1.140 | 1.140 |
| Short-term debt | 452 | 1.429 | 796 | 1.449 |
| Total debt | 452 | 1.429 | 1.936 | 2.589 |
EBITDA margin
-21828600.0%
This company
15.8%
Market median
-138155796% vs market
20212024
Equity ratio
0.9%
This company
38.2%
Market median
-98% vs market
20212024
Return on equity
-773.0%
This company
18.4%
Market median
-4301% vs market
20212024
Net profit margin
-20454700.0%
This company
8.1%
Market median
-252527260% vs market
20212024
Asset turnover
-0.00×
This company
1.12×
Market median
-100% vs market
20212024
Debt / equity
106.55×
This company
0.62×
Market median
-17085% vs market
20212024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2020-07-07 – 2021-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
AP Management | Management | 2020 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2020 | — | — | |
| Chairman | 2020 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Rocha Holding ApS | Company | 66.7% | 66.7% | 2023 |
MY.Invest ApS | Company | 10.0% | 10.0% | 2023 |
Lokalt LIV A/S Ølgod, Ansager, Tistrup og Skovlund | Company | 15.0% | 15.0% | 2020 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Rocha Holding ApS
INSULIN RESET ApS Board members of INSULIN RESET ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Angela Pereira da Rocha | Management | 0 companies |
| Jesper Henrik Svender | Board of Directors | 0 companies |
| Hans Barslund | Chairman | 0 companies |